 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
GE's Clarient Gains IP Rights from Insight Genetics to Develop PCR-based ALK Test
June 06, 2012
GE's Clarient Gains IP Rights from Insight Genetics to Develop PCR-based ALK Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche Unveils Higher-Throughput Cobas Systems as it Maps out MDx Strategy
May 23, 2013 / PCR Insider - Studies Indicate Effectiveness of New LAMP-based Malaria Test in Modern Labs, Endemic Countries
May 23, 2013 / PCR Insider - Wave 80 Aims to Begin Clinical Trials this Year for POC MDx System, HIV Viral Load Assay
May 23, 2013 / PCR Insider - Thermo Fisher Contacted Life Tech in 2011 about Possible Acquisition; Document Discloses Other Bidders
May 22, 2013 / GenomeWeb Daily News - NIH Team Presents Findings from Fungi-focused Study of Skin Microbiome
May 22, 2013 / GenomeWeb Daily News